Director, Health Economic & Outcomes Research

Responsibilities

The Health Economics & Outcomes Research Director will be responsible for the access evidence planning and execution for BioMarin’s Skeletal Conditions business. The individual will lead the global compound access evidence strategic plan and tactical execution in alignment with the compound value & access strategy. They will:

• Plan, develop, and disseminate HEOR evidence to demonstrate the value of BioMarin’s assets.
• Actively influence and shape evidence generation delivered by cross-functional partners (i.e. Clinical Sciences, Medical Affairs) to ensure that they meet the needs of Market Access.
• Be an acknowledged subject matter expert supporting country and regional market access leads with evidence communication to external stakeholders including payers and health technology assessment (HTA) agencies.
  
  
  

The role is part of the Global HEOR team which sits within Global Value Access & Strategic Pricing. It will include a high degree of cross-functional collaboration with medical affairs, regulatory affairs, clinical sciences, data sciences, patient affairs and with regional and local market access teams. The role will also involve liaising with external stakeholders including payers, HTA agencies, clinicians and patient groups. RESPONSIBILITIES Market access evidence strategy

• Lead the global compound access evidence plan in support of the access strategy.
• Provide the market access voice in global cross-functional evidence forums including the Value & Access Team and the Integrated Evidence Team.
• Mentor and coach HEOR and Access team members in value demonstration methods and communication.
  
  
  

Market access evidence generation

• Lead HEOR evidence generation, synthesis and dissemination.
• Project manage vendors to deliver high quality deliverables on time and on budget.
• Review and influence clinical and medical activities including trial design, endpoints and analytical approaches to ensure they meet payer needs.
• Lead secondary analyses of clinical data to address market access needs.
  
  
  

Country access and reimbursement support

• Interpret and communicate evidence to internal stakeholders including country and regional market access teams and cross-functional partners.
• Support country access teams with adaptation of materials and review/sign-off of reimbursement submissions.
• Represent BioMarin at external meetings with payers and HTA agencies as required.
  
  
  

EXPERIENCE

• 10+ years of HEOR experience obtained within the pharmaceutical industry.
• Demonstrated ability to deliver a range of HEOR evidence projects including cost-effectiveness models, budget impact models, systematic literature reviews and real-world data analysis.
• History of working cross functionally, influencing, and gaining alignment across Market Access, Commercial, Medical, Clinical and Regulatory departments.
• Comfortable interacting with external decision makers, health economists, clinical experts and patient organizations.
• Sound knowledge and experience of different payer architypes and appreciation for the broader market access environment – global or multi-country experience preferred.
• Excellent verbal and written communication, collaboration, influence, strategic, analytical and problem-solving skills are required.
• Working knowledge of common statistical packages and reference management software preferred.
  
  
  

EDUCATION

• Postgraduate qualifications (Masters or PhD) in public health, health economics, epidemiology or statistics
  
  
  

Note: This description is not intended to be all-inclusive, or a limitation of the duties of the position. It is intended to describe the general nature of the job that may include other duties as assumed or assigned.

Equal Opportunity Employer/Veterans/Disabled

An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.